Bayer HealthCare

News

05/08/08, Research & Development Bayer and Regeneron start additional Phase 3 Study for VEGF Trap-Eye in Wet Age-related Macular Degeneration International study to evaluate efficacy and safety in treating a leading cause of blindness more

05/06/08, Research & Development Bayer Schering Pharma to market new low-dose oral contraceptive YAZ® in Europe Berlin, May 6, 2008 – Bayer Schering Pharma’s new low-dose oral contraceptive YAZ® has been approved in the EU.YAZ® will be the first oral contraceptive on the European market containin... more

04/28/08, Research & Development Bayer HealthCare and Regeneron Announce Encouraging 32-week Follow-Up Results from a Phase 2 Study of VEGF Trap-Eye in Age-related Macular Degeneration Gains in visual acuity achieved in initial 12-week fixed dosing phase of study maintained in PRN (as-needed) dosing phase more

Bayer HealthCare supports IFPMA Assistance to the WHO-based Special Programme for Research and Training in Tropical Diseases (TDR) Bayer HealthCare has donated a six-figure sum to the WHO-based Special Programme for Research and Training in Tropical Diseases (TDR), co-sponsored by UNICEF, UNDP, the World Bank and WHO. The donation contributes to the USD 1,000,000 the International ... more

Media Contacts Journalists will find their contact persons here. more
Press archive Here you will find the press archive. more

Here you will find background information about the Bayer HealthCare AG. more